Analysis of phenotype and pathogenic variants in a Chinese pedigree affected with Multiple synostoses syndrome type 1.
10.3760/cma.j.cn511374-20221017-00693
- Author:
Wenyuan ZHANG
1
;
Lu MAO
;
Jinhui ZHANG
;
Hongen XU
;
Bei CHEN
Author Information
1. Department of Otology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. fccchenb@zzu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Female;
Humans;
DNA Copy Number Variations;
East Asian People;
Pedigree;
Synostosis;
Phenotype
- From:
Chinese Journal of Medical Genetics
2023;40(9):1118-1123
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the clinical and genetic characteristics of a Chinese pedigree affected with Multiple synostoses syndrome type 1 (SYNS1).
METHODS:Clinical data of the proband and her family members were collected. Genomic DNA was extracted from peripheral blood samples. Whole-exome sequencing (WES) and whole-genome sequencing (WGS) were carried out for the proband and her parents.
RESULTS:The pedigree has comprised of 14 members from three generations, of whom six had manifested hearing loss, with other symptoms including proximal symphalangism, hemicylindrical nose, amblyopia, strabismus, brachydactyly, incomplete syndactyly, which fulfilled the diagnostic criteria for SYNS1. WES had detected no pathogenic single nucleotide variants and insertion-deletion (InDel) in the coding region of the NOG gene, whilst copy number variation (CNV) analysis indicated that there was a heterozygous deletion involving the NOG gene. WGS revealed a heterozygous deletion (54171786_55143998) in 17q22 of the proband. The CNV was classified as pathogenic based on the guidelines from the American College of Medical Genetics and Genomics (ACMG).
CONCLUSION:The heterozygous deletion in 17p22 involving the NOG gene probably underlay the pathogenesis of SYNS1 in this pedigree. Above finding has enriched the mutational spectrum of NOG. CNV should be considered when conventional sequencing has failed to detect any pathogenic variants in such patients.
